108 related articles for article (PubMed ID: 19509511)
1. In vivo quantification of 18f-fdg uptake in human placenta during early pregnancy.
Zanotti-Fregonara P; Jan S; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
Health Phys; 2009 Jul; 97(1):82-5. PubMed ID: 19509511
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
[TBL] [Abstract][Full Text] [Related]
3. Absorbed 18F-FDG dose to the fetus during early pregnancy.
Zanotti-Fregonara P; Jan S; Taieb D; Cammilleri S; Trébossen R; Hindié E; Mundler O
J Nucl Med; 2010 May; 51(5):803-5. PubMed ID: 20395321
[TBL] [Abstract][Full Text] [Related]
4. Proposed addendum to previously published fetal dose estimate tables for 18F-FDG.
Stabin MG
J Nucl Med; 2004 Apr; 45(4):634-5. PubMed ID: 15073260
[TBL] [Abstract][Full Text] [Related]
5. Physiologic thymic uptake of 18F-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment.
Jerushalmi J; Frenkel A; Bar-Shalom R; Khoury J; Israel O
J Nucl Med; 2009 Jun; 50(6):849-53. PubMed ID: 19443604
[TBL] [Abstract][Full Text] [Related]
6. Giant cell arteritis on 18F-FDG PET/CT.
Heston TF; Szabo Z
Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
[TBL] [Abstract][Full Text] [Related]
7. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
8. A method to quantify at late imaging a release rate of 18F-FDG in tissues.
Laffon E; Allard M; Marthan R; Ducassou D
C R Biol; 2005 Aug; 328(8):767-72. PubMed ID: 16125654
[TBL] [Abstract][Full Text] [Related]
9. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
Dunn JT; Anthony K; Amiel SA; Marsden PK
J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
Coha B; Radmilović K; Gardasanić J; Daković M; Stefanić M; Latić A; Mitrecić D
Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG.
Pencharz D; McMeekin H; Wagner T; Wickham F
Nucl Med Commun; 2016 Aug; 37(8):860-4. PubMed ID: 27115065
[TBL] [Abstract][Full Text] [Related]
12. New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms.
Zanotti-Fregonara P; Chastan M; Edet-Sanson A; Ekmekcioglu O; Erdogan EB; Hapdey S; Hindie E; Stabin MG
J Nucl Med; 2016 Nov; 57(11):1760-1763. PubMed ID: 27261522
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose to the fetus from [(18)F]-FDG administration during the second trimester of pregnancy.
Zanotti-Fregonara P; Koroscil TM; Mantil J; Satter M
Health Phys; 2012 Feb; 102(2):217-9. PubMed ID: 22217594
[TBL] [Abstract][Full Text] [Related]
14. Maternal-fetal in vivo imaging: a combined PET and MRI study.
Benveniste H; Fowler JS; Rooney WD; Moller DH; Backus WW; Warner DA; Carter P; King P; Scharf B; Alexoff DA; Ma Y; Vaska P; Schlyer D; Volkow ND; ;
J Nucl Med; 2003 Sep; 44(9):1522-30. PubMed ID: 12960202
[TBL] [Abstract][Full Text] [Related]
15. Practical Aspects of 18F-FDG PET When Receiving 18F-FDG from a Distant Supplier.
Ducharme J; Goertzen AL; Patterson J; Demeter S
J Nucl Med Technol; 2009 Sep; 37(3):164-9. PubMed ID: 19692456
[TBL] [Abstract][Full Text] [Related]
16. Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.
Cheon GJ; Kim MS; Lee JA; Lee SY; Cho WH; Song WS; Koh JS; Yoo JY; Oh DH; Shin DS; Jeon DG
J Nucl Med; 2009 Sep; 50(9):1435-40. PubMed ID: 19690035
[TBL] [Abstract][Full Text] [Related]
17. [IL-10 suppresses inflammatory granuloma uptake of 18F-FDG in rats].
He J; Ye Q; Zhi K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 37(7):748-51. PubMed ID: 22886224
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-MDP and 18F-FDG uptake in calcified metastatic lesions from ovarian papillary serous adenocarcinoma.
Ozulker T; Ozulker F; Ozpacaci T
Hell J Nucl Med; 2009; 12(3):287-8. PubMed ID: 19936349
[No Abstract] [Full Text] [Related]
19. Treatment of breast tumor cells in vitro with the mitochondrial membrane potential dissipater valinomycin increases 18F-FDG incorporation.
Smith TA; Blaylock MG
J Nucl Med; 2007 Aug; 48(8):1308-12. PubMed ID: 17673425
[TBL] [Abstract][Full Text] [Related]
20. Maternal-fetal transport kinetics of carboplatin in the perfused human placental lobule: in vitro study.
Al-Saleh E; Nandakumaran M; Al-Rashdan I; Al-Harmi J; Al-Shammari M
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):695-701. PubMed ID: 17701670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]